three months ended March 31, 2025 and 2024, (iii) the Consolidated balance sheets (unaudited) as of March 31, 2025 and December 31, 2024, (iv) the Consolidated statements of changes in stockholders’ equity (unaudited) for the three months ended March 31, 2025 and 2024, (v) the Consolidated statements of cash flows (unaudited) for the three months ended March 31, 2025 and 2024, and (vi) the Notes to Consolidated Financial Statements (unaudited).
183
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
184